A comparative ethical analysis of the Egyptian clinical research lawBMC MEDICAL ETHICSIF3.12024-04-300OAAI
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancerCCNK/CDK12的降解是结直肠癌的药物脆弱性CELL REPORTSIF6.92021-07-0150OAAI
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancerBRITISH JOURNAL OF CANCERIF6.81999-02-2611OAAI
The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphomaLEUKEMIAIF13.41998-12-0839PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向